Harvard Bioscience, Inc. is a developer, manufacturer and seller of technologies, products and services that enable fundamental advances in life science applications, including research, pharmaceutical and therapy discovery, bioproduction and preclinical testing for pharmaceutical and therapy development. Its products and services are sold globally to customers ranging from renowned academic institutions and government laboratories to pharmaceutical, biotechnology and contract research organizations (CROs). Its two product categories are cellular and molecular technology (CMT) and Preclinical. The CMT product family is primarily composed of products supporting research related to molecular, cellular, organ and organoid technologies. The Preclinical product family includes products that support the preclinical research and testing phase for drug development, and in particular, testing related to data collection and analysis for safety and regulatory compliance.
企業コードHBIO
会社名Harvard Bioscience Inc
上場日Oct 21, 2013
最高経営責任者「CEO」Mr. John D. Duke
従業員数330
証券種類Ordinary Share
決算期末Oct 21
本社所在地84 October Hill Rd
都市HOLLISTON
証券取引所NASDAQ Global Market Consolidated
国United States of America
郵便番号01746-1371
電話番号15088938999
ウェブサイトhttps://www.harvardbioscience.com/
企業コードHBIO
上場日Oct 21, 2013
最高経営責任者「CEO」Mr. John D. Duke
過去5年間の配当金総支払額は
0.00
米ドルである。

データなし